These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9635241)

  • 1. In vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative Staphylococcus.
    Raymond J; Vedel G; Bergeret M
    Diagn Microbiol Infect Dis; 1998 Jul; 31(3):481-3. PubMed ID: 9635241
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci.
    Raymond J; Vedel G; Bergeret M
    J Antimicrob Chemother; 1996 Dec; 38(6):1067-71. PubMed ID: 9023655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro bactericidal activity of cefpirome and cefamandole in combination with glycopeptides against methicillin-resistant Staphylococcus aureus.
    Bergeret M; Raymond J
    J Antimicrob Chemother; 1999 Feb; 43(2):291-4. PubMed ID: 11252338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of cefpirome and vancomycin in combination against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus.
    Carricajo A; Vermesch R; Aubert G
    Clin Microbiol Infect; 2001 Apr; 7(4):218-26. PubMed ID: 11422245
    [No Abstract]   [Full Text] [Related]  

  • 5. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
    Seibert G; Isert D; Klesel N; Limbert M; Markus A; Schrinner E
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():25-30. PubMed ID: 1601753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the bactericidal activity of cefepime and cefpirome in association with glycopeptides against Staphylococci sensitive and resistant to methicillin].
    Husson MO; Fruchart A; Izard D
    Pathol Biol (Paris); 1998 Apr; 46(4):279-83. PubMed ID: 9769909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
    Kucukates E; Nalan Karayel E; Gultekin N; Okuyan E; Kansiz E; Gurler N
    Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323
    [No Abstract]   [Full Text] [Related]  

  • 8. Cefpirome susceptibility in staphylococci isolates.
    Poiată A; Tuchiluş C; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):276-9. PubMed ID: 17595881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination effect of vancomycin and cefpirome against methicillin-resistant Staphylococcus aureus in vitro--antimicrobial activities in postantibiotic phase].
    Hasegawa H; Kanai A; Otoguro K; Shimizu K
    Kansenshogaku Zasshi; 1996 Feb; 70(2):151-60. PubMed ID: 8851387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of vancomycin-intermediate Staphylococcus species in southern India.
    Menezes GA; Harish BN; Sujatha S; Vinothini K; Parija SC
    J Med Microbiol; 2008 Jul; 57(Pt 7):911-912. PubMed ID: 18566156
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
    Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.
    Del Bene VE; John JF; Twitty JA; Lewis JW
    J Infect Dis; 1986 Aug; 154(2):349-52. PubMed ID: 2941491
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin.
    Aritaka N; Hanaki H; Cui L; Hiramatsu K
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1292-4. PubMed ID: 11257050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of cefpirome (HR 810) against enterococci and staphylococci.
    Piacentini E; Amalfitano G; Ligozzi M; Canepari P; Fontana R
    J Chemother; 1992 Dec; 4(6):338-41. PubMed ID: 1287135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
    Mordenti JJ; Davis RH; Lammel CJ; Brooks GF
    Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycopeptide resistance amongst Staphylococcus spp.
    van den Braak N; van Belkum A; te Witt R; Verbrugh HA; Endtz HP
    J Antimicrob Chemother; 1998 Nov; 42(5):673-5. PubMed ID: 9848458
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci.
    Naylor PT; Myrvik QN; Gristina A
    Clin Orthop Relat Res; 1990 Dec; (261):126-33. PubMed ID: 2173986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of LY146032 and vancomycin against coagulase-negative staphylococci.
    Low DE; Poon R
    Eur J Clin Microbiol; 1987 Apr; 6(2):190. PubMed ID: 3595581
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
    Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K
    Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro and in-vivo activity of cefpirome (HR 810) against methicillin-susceptible and -resistant Staphylococcus aureus and Streptococcus faecalis.
    Eng RH; Cherubin CE; Smith SM; Buccini F; Harris R
    J Antimicrob Chemother; 1989 Mar; 23(3):373-81. PubMed ID: 2499565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.